CVKD / Cadrenal Therapeutics, Inc. - 机构投资人持股 - 买家

肾上腺治疗公司

US ˙ NasdaqCM

机构和基金投资人持股 - 买家

在肾上腺治疗公司中开设新头寸的主要持有者包括贝莱德公司, IWC - iShares 微型股 ETF, 雷蒙德詹姆斯金融公司, EQ ADVISORS TRUST - 1290 VT 微型资本投资组合 IB 级, 和港口投资公司 .

本页面显示了上一报告期内增持或开仓的上市机构、基金和大股东的股权结构变化绿色行表示新头寸。点击链接图标查看完整的交易历史记录。

升级以解锁高级数据。

文件日期	来源	投资者		类型	平均价格 (Est)	股份	Δ 股份 (%)	报告价值 ($1000)	Δ 价值 (%)	投资组合配置 (%)
2025-07-24	NP	FCFMX - 富达系列总市场指数基金 This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				2,608	70.57	35	17.24
2025-08-12	13F	普利股权公司				0		0
2025-08-12	13F	贝莱德公司				3,282		40
2025-08-15	13F	塔尔研究资本有限责任公司（TRC）				136		2
2025-08-26	NP	EQ ADVISORS TRUST - 1290 VT 微型资本投资组合 IB 级				264		3
2025-07-28	13F	港口投资公司				100		1
2025-08-27	NP	VEXMX - 先锋扩展市场指数基金投资者股票 This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				14,590	25.47	176	-14.63
2025-08-14	13F	雷蒙德詹姆斯金融公司				1,917		23
2025-08-08	13F	Geode资本管理有限公司				12,710	5.16	153	-28.17
2025-07-24	NP	FSMAX - 富达扩展市场指数基金 This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				6,956	2.87	93	-28.12
2025-08-11	13F	先锋集团公司				48,595	6.49	586	-27.24
2025-08-14	13F	美国银行 /de/				14	27.27	0
2025-08-28	NP	IWC - iShares 微型股 ETF This fund is a listed as child fund of BlackRock Inc. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				3,018		36

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.